On the other hand, the action of Pro3 in attenuating anti-atherogenic action without affecting HbA1c suggests that the enhancement of active GIP by DPP-4 inhibition suppresses atherosclerosis through direct action. This evidence concerns the gene GIP and atherosclerosis.